Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective.
Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
Right after reporting that the month of August had an unusual four acquisitions, we had nearly as many in just the first week of September. It seems, going purely on volume, like M&A in digital health is picking up. This week we saw iHealth Labs acquire eDevice for $100 million, HMS Holdings buying Essette for $20 million, and HCA buying Mobile Heartbeat for an undisclosed amount. For a round...
Skip Fleshman, a Managing Partner at Asset Management Ventures, shared a few tips for those mobile health startups looking to become more that just "one-trick pony" developers of successful apps. In order to capitalize on their real potential and become a long-term, viable business, Fleshman has a few lessons learned to share based on his firm's investments in a number of health startups,...
